Fig. 4From: Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signaturesThe metabolic effect of drug treatment on lung cancer cell lines. a: treatment agent erlotinib; b: treatment agent AEW541Back to article page